Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 1 (1)
P 2 (1)

Trial Status

Recruiting4
Not Yet Recruiting2
Active Not Recruiting1

Clinical Trials (7)

Showing 7 of 7 trials
NCT06902688Not ApplicableRecruiting

Timely Ordering of Pharmacogenetic Testing

NCT06566105Not ApplicableRecruiting

The Liver BIoBank Lombardia of Fatty Liver

NCT07219862Not ApplicableNot Yet Recruiting

Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

NCT06895733Phase 1Recruiting

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

NCT06776198Not Yet Recruiting

Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

NCT06739395Phase 2Recruiting

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

NCT06642506Active Not Recruiting

Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

Showing all 7 trials

Research Network

Activity Timeline